Physician profile
Elizabeth Vaught
NPI 1093175630
$1,497.02
in general payments reported to CMS, 2019-2025
10 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $100 · 2023: $114 · 2024: $33.06 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151 · Travel and Lodging: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.18 |
| Travel and Lodging | $245.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $886.21 | 2025 | Watchman Flx, General - Atherectomy |
| Astrazeneca Pharmaceuticals LP | $114.30 | 2025 | Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.12 | 2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.47 | 2022 | |
| Surmodics, INC. | $98.77 | 2025 | Pounce LP Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Abiomed | $72.81 | 2025 | |
| Medtronic, INC. | $37.52 | 2025 | Onyx Frontier, Symplicity G3 |
| Amgen INC. | $33.56 | 2024-2025 | Repatha, Repatha |
| Stryker Corporation | $20.54 | 2025 | Artix Mt |
| Novartis Pharmaceuticals Corporation | $18.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Vaught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.